USPTO serial 85080250
NANOFOCUS
Reviewed by CopyMark Law Group
Reg. 4212224Status 710
- Filing date
- Status date
- Registration date
- Sep 25, 2012
- Examiner
- KEARNEY, COLLEEN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with NANOFOCUS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Doreen L. Costa
DOREEN L. COSTA BAKER BOTTS LLP30 ROCKEFELLER PLZ STE 4340NEW YORK, NY 10112-4498UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical powders and emulsifiers for use in the manufacture of health foods and supplements; chemical powders and emulsifiers for use in the manufacture of cosmetics; chemicals for use in the manufacture of pharmaceutical preparations; chemical preparations for general industrial manufacturing | SECTION 8 - CANCELLED | — |
| 003 | Cosmetics; non-medicated toiletries; soaps; detergents for household use; dentifrices, fragrances and perfumery, incenses; false nails; false eyelashes; Anti-static preparations for household purposes; De-greasing preparations for household purposes; rust removing preparations; stain removing preparations; fabric softeners for laundry use; laundry bleaches | SECTION 8 - CANCELLED | — |
| 005 | Pharmaceutical preparations, namely, central nervous system agents, peripheral nervous system agents, sensory organ agents, miscellaneous nervous system and sensory organ agents, cardiovascular agents, respiratory organ agents, digestive organ agents, hormones, urogenital and anal organ agents, epidermides, dental preparations, miscellaneous organ agents, vitamins, nutrients, tonics, blood and body fluid agents, dialysis agents, miscellaneous metabolism agents, cellular function activating agents, antineoplastics, radioactive drugs, allergic agents, miscellaneous cellular function agents, crude drugs and traditional Chinese medicines, antibiotics, chemotherapeutics, biological preparations, parasitics (systemic), pathogenic organism agents, dispensing medicines, intracorporeal diagnostic agents, public health agents, extracorporeal diagnostic agents, non-main therapeutic purpose agents, alkaloidal narcotics, non-alkaloidal narcotics and miscellaneous narcotics; sanitary preparations for medical use; sanitary masks for medical purposes; drug delivery agents in the form of pharmaceutical wafers and gelatin-starch films for providing controlled release of the active ingredients for a wide variety of pharmaceuticals; gauze; empty capsules for pharmaceuticals; eye patches for medical purposes; bandages for skin wounds for use on the ear; sanitary pads; menstruation tampons; sanitary napkins; sanitary panties; cotton for medical purposes; bandages for skin wounds, medical plasters, medical dressings; medical dressing in liquid form, medical dressing containing collodion for pharmaceutical purposes; breast-nursing pads; dental composite materials; incontinence diapers; dietetic lactic sugar for medical use; powdered milk for infants; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing astaxanthin as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing ceramide as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing vitamin E as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing lycopene as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing vitamin C as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing selenium yeast as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing zinc yeast as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing salacia extract powder as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing onion integument extract as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing chitosan as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing apple polyphenol as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing tea catechin as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing chromium yeast as a principal ingredient | SECTION 8 - CANCELLED | — |
| 035 | Retail store services and wholesale store services featuring pharmaceuticals, sanitary preparations and medical supplies; retail store services and wholesale store services featuring cosmetics and toiletries; retail store services or wholesale store services featuring processed foods; online retail store services and wholesale store services featuring pharmaceuticals, sanitary preparations and medical supplies; online retail store services and wholesale store services featuring cosmetics and toiletries; online retail store services and wholesale store services featuring processed foods; advertising in websites on the Internet; providing businesses information through websites on the Internet; providing consumer products information through websites on the Internet | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by FUJIFILM Corporation
- Other trademarks owned by FUJIFILM Corporation
- Other trademarks owned by FUJIFILM Corporation
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 035
- Similar marks named NANOFOCUS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 26, 2019 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Sep 25, 2017 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Sep 25, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 10, 2012 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 10, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 20, 2012 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 5, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 3, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 10, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 10, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 7, 2012 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Nov 7, 2011 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Nov 7, 2011 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Nov 7, 2011 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Oct 17, 2011 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Apr 14, 2011 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 14, 2011 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 14, 2011 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 24, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 24, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 22, 2011 | ALIE | ASSIGNED TO LIE | — |
| Mar 19, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 21, 2010 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 21, 2010 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 21, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 13, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 13, 2010 | MPMK | NOTICE OF PSEUDO MARK MAILED | — |
| Jul 12, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 12, 2010 | NWAP | NEW APPLICATION ENTERED | — |